Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanezumab for pain in interstitial cystitis
NCT00601484Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2008
- Primary completion
- Apr 2009
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tanezumab in interstitial cystitis (IC), sponsored by Pfizer. Started Mar 2008; status: completed.
02
Drugs
tanezumab
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT00601484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00601484.